Answers are grounded in this paper and cite their sources.
Background: International studies disagree on which ABO blood group carries the highest cardiovascular risk: the largest prospective cohort evidence (Nurses' Health Study/Health Professionals Follow-up Study, USA) has implicated group AB, a large meta-analysis has implicated group A, and case–control studies from Turkey, Switzerland, Pakistan, and India have implicated group B. No study conducted in Syria has previously examined the joint distribution of ABO and Rhesus (Rh) phenotypes in relation to cardiac disease. This study aimed to determine whether ABO blood group and Rh factor are independently associated with cardiac disease in a Syrian population. Methods: We conducted a case–control study of 2,239 participants (1,005 cardiac cases; 1,234 controls without known cardiac disease) recruited from hospitals and clinics across multiple governorates of Syria, with data collected between 2015 and 2026. ABO/Rh phenotype and demographic characteristics were recorded retrospectively for both groups. Associations were tested using chi-square tests, independent-samples t-tests, and multivariable logistic regression adjusted for age and sex, with blood group O and phenotype O+ as reference categories. Results: Blood group A was most prevalent (43.23%), followed by O (33.68%), B (15.19%), and AB (7.91%); 85.98% of participants were Rh-positive. On adjusted analysis, blood group B was independently associated with case status relative to O (adjusted odds ratio [aOR] 2.50, p<0.001), as was Rh-positivity (aOR 1.63, p=0.002). When ABO and Rh were analysed jointly, the association was concentrated in the B+ phenotype (aOR 2.61, 95% CI 1.85–3.69, p<0.001), while B− carriers showed no excess risk (aOR 1.16, p=0.614). The O− phenotype was independently associated with reduced odds (aOR 0.52, 95% CI 0.33–0.83, p=0.007). Blood group AB showed no significant association at either the group level or within either Rh stratum. Age and male sex remained the strongest independent demographic correlates of case status (both p<0.001). Conclusions: In this Syrian case–control sample, blood group B and Rh-positivity — and specifically their combination (B+) — were independently associated with cardiac disease, while O− was independently associated with reduced odds and AB showed no association. This B-predominant pattern aligns with regional case–control evidence implicating group B but differs from the largest Western prospective cohort data implicating group AB and from a large meta-analysis implicating group A, supporting population-specific heterogeneity in ABO-related cardiovascular risk rather than a single universal pattern. Trial registration: Not applicable.
No takes yet. Share an insight, caveat, or question.
Alyounes et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: